Kate Gannon, deputy director of programme funding at Orbis UK, told OT: “With our dedicated partners, we’re working to ensure ...

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target cut by research analysts at Piper Sandler from $1,195.00 to $1,013.00 in a report issued on Monday,Benzinga reports. The ...